Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jun 22:3:58.
doi: 10.3389/fped.2015.00058. eCollection 2015.

Hypoxic Conditioning as a New Therapeutic Modality

Affiliations
Review

Hypoxic Conditioning as a New Therapeutic Modality

Samuel Verges et al. Front Pediatr. .

Abstract

Preconditioning refers to a procedure by which a single noxious stimulus below the threshold of damage is applied to the tissue in order to increase resistance to the same or even different noxious stimuli given above the threshold of damage. Hypoxic preconditioning relies on complex and active defenses that organisms have developed to counter the adverse consequences of oxygen deprivation. The protection it confers against ischemic attack for instance as well as the underlying biological mechanisms have been extensively investigated in animal models. Based on these data, hypoxic conditioning (consisting in recurrent exposure to hypoxia) has been suggested a potential non-pharmacological therapeutic intervention to enhance some physiological functions in individuals in whom acute or chronic pathological events are anticipated or existing. In addition to healthy subjects, some benefits have been reported in patients with cardiovascular and pulmonary diseases as well as in overweight and obese individuals. Hypoxic conditioning consisting in sessions of intermittent exposure to moderate hypoxia repeated over several weeks may induce hematological, vascular, metabolic, and neurological effects. This review addresses the existing evidence regarding the use of hypoxic conditioning as a potential therapeutic modality, and emphasizes on many remaining issues to clarify and future researches to be performed in the field.

Keywords: conditioning; dose; humans; intermittent hypoxia; murines; therapeutics.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Infarct size (I) expressed as a percentage of ventricles (V) assessed after a no-flow global ischemia (30 min)-reperfusion (120 min) sequence in groups of mice exposed to 4 h of normoxia (S), intermittent hypoxia (IH, FiO2 = 5 or 10%), or chronic hypoxia (CH). *P < 0.05 versus the other groups; §P < 0.05 versus S; 4 h, and IH10, 4 h. From Ref. (20).
Figure 2
Figure 2
Schematic representation of the continuum from normoxia to severe hypoxia including hypoxic exposure leading to hypoxic conditioning.

References

    1. Lavie L. Obstructive sleep apnoea syndrome – an oxidative stress disorder. Sleep Med Rev (2003) 7(1):35–51.10.1053/smrv.2002.0261 - DOI - PubMed
    1. Baguet JP, Barone-Rochette G, Tamisier R, Levy P, Pepin JL. Mechanisms of cardiac dysfunction in obstructive sleep apnea. Nat Rev Cardiol (2012) 9(12):679–88.10.1038/nrcardio.2012.141 - DOI - PubMed
    1. Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med (2000) 162(2 Pt 1):566–70.10.1164/ajrccm.162.2.9908091 - DOI - PubMed
    1. Garvey JF, Taylor CT, McNicholas WT. Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J (2009) 33(5):1195–205.10.1183/09031936.00111208 - DOI - PubMed
    1. Lévy P, Tamisier R, Minville C, Launois S, Pépin JL. Sleep apnoea syndrome in 2011: current concepts and future directions. Eur Respir Rev (2011) 20(121):134–46.10.1183/09059180.00003111 - DOI - PMC - PubMed

LinkOut - more resources